Anti-CD47 (magrolimab biosimilar) mAb
| Common Name |
Hu5F9-G4 |
|---|---|
| Buffer | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Guarantee | 12 months from date of dispatch |
| Catalog Number | BME100001 |
|---|---|
| Package | 50 μg $80.00 ; 100 μg $160.00 |
| Delivery | In Stock |
| Synonyms | CD47, MER6, IAP |
| Host Species | Chimeric Humanized |
| IgG type | IgG4 |
| Clonality | Monoclonal |
| Formulation | Powder |
| Purification | Purified from cell culture supernatant by affinity chromatography |
| Reactivity | Human |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Storage | Store at -20°C (Avoid repeated freezing and thawing) |
| Usage | Research use only |
| Images |
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD47, mFc-His tagged protein (PME100008) can bind Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD47(A) were surface stained with anti-CD47 neutralizing antibody 1μg/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Datasheet | Download | COA | Download |
|---|---|---|---|
| MSDS | Download | ||
简体中文
English
